Skip to main content

Ingevity Corp

NGVT
Exchange
NYSE
Industry
Chemicals & Allied Products
SEC CIK
0001653477

In the last 90 days, Ingevity Corp insiders filed 0 open-market purchases and 3 sales; 315 institutions reported holding it in 13F filings for Q2 2026, worth $2.62B in total; no superinvestor holds it.

Holders of 5% or more of NGVT

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Ingevity Corp, largest stake first. The change is against the holder's previous filing.

Holders of 5% or more of NGVT
HolderLatest formStakeChangeFirst filedLatest filingFiling
BlackRock, Inc.13G/A15.50%5.64M shares–Apr 30, 20251 filingApr 30, 2025SEC

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

3 Schedule 13D and 13G filings on Ingevity Corp, newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on NGVT
Filed (ET)FilerFormStakeChangeEvent dateFiling
May 15, 20267:34 AM ETWellington Management Group LLPand 2 others13G/A4.20%1.49M shares–Below 5%Mar 31, 2026SEC
Apr 30, 202610:23 AM ETVanguard Capital Management LLC13G5.26%1.85M sharesNewMar 31, 2026SEC
Apr 29, 20261:48 PM ETVanguard Portfolio Management LLC13G6.27%2.21M sharesNewMar 31, 2026SEC
Mar 27, 20269:53 AM ETVanguard Group Inc13G/A0.00%0 shares–Below 5%Mar 13, 2026SEC
Oct 24, 202510:04 AM ETVictory Capital Management Inc13G/A2.15%782.9K shares–Below 5%Sep 30, 2025SEC
Apr 30, 20257:39 AM ETBlackRock, Inc.13G/A15.50%5.64M shares–Mar 31, 2025SEC

Form 144: proposed insider sales

Notices from officers, directors and other affiliates planning to sell Ingevity Corp shares.

No Form 144 notices for Ingevity Corp are on file.